All Headline News - Study Says Antidepressant May Calm Irritable Bowel Syndrome (IBS) - August .
Content Services Client Login About Contact Jobs Submit News Tip
TOP STORIES BUSINESS ENTERTAINMENT POLITICS TECHNOLOGY Study Says Antidepressant May Calm Irritable Bowel Syndrome (IBS) Irritable Bowel Syndrome
Julie Farby - All Headline News Staff Writer
New York, NY (AHN)-According to a new trial study, treatment with so-called SSRI antidepressants seems to reduce abdominal symptoms and promote overall well being in people with irritable bowel syndrome (IBS).
Irritable Bowel
Dr. Jan Tack from University of Leuven in Belgium and colleagues note in the
Syndrome?
journal Gut, these antidepressants "could be considered in IBS patients who do
not respond well enough to a classical treatment approach."
Secret That Eliminates IBS Fast! Guaranteed.
Tack tells Reuters Health, SSRIs are often used in the treatment of IBS
"although evidence of their efficacy is scarce."
The investigative team reports, "After three and six weeks of treatment, citalopram significantly improved abdominal pain, bloating, impact of symptoms
Tummy troubles?
on daily life, and overall well being compared with placebo."
Proven natural relief Iberogast - trial in
Citalopram's ability to alleviate several IBS symptoms seems unrelated to its
effect on depression or anxiety, because depressed patients were excluded
from the study and changes in mood did not correlate with IBS symptom improvement.
Tack and his colleagues tell Reuters, "Citalopram provided symptomatic benefit of rapid onset, was well tolerated, and was not associated with the side effects
IBS Treatment Review
of tricyclic antidepressants, such as drowsiness or constipation."
treatments for 2006! www.IBS-Treatment-Reviews.com
Bowel Health Information
Copyright All Headline News - All rights reserved.
Redistribution, republication. syndication, rewriting or broadcast is expressly prohibited without the prior
written consent of All Headline News. AHN shall not be liable of delays, errors or omissions in the
content, or for any actions taken in reliance thereon.
All Headline News Corp. All Rights Reserved.
Home | Privacy | Terms of Use | Contact | Services
http://www.allheadlinenews.com/articles/7004339785
Original article Midterm outcomes of prospective, randomized, single-center study of the Janus tacrolimus-eluting stent for treatment of native coronary artery lesions HAN Ya-ling, WANG Shou-li, JING Quan-min, YU Hai-bo, WANG Bin, MA Ying-yan, LUAN Bo and WANG Geng Keywords: drug-eluting stent; acute myocardial infarction; angioplasty, transluminal; percutaneous coronary B
Grey Scrubs: Medical Dramas Introduction As with every Chinese New Year, reunion dinners await and it always seems that relatives will corner you with the mostinane questions, until they remember your profession that is, after which they launch into the same tired dogmatic line ofquestioning: “So how’s your doctor job? Save lives or not? How many lives you save today? Got do operation o